This new Part D Savings Model (which will take effect in 2021) will allow Manufacturers and Part D Plans to offer a flat monthly copay of $35 (or less) for the entire year.
For beneficiaries that enroll in these Plans for 2021, we are projecting an annual savings of $700+ for their Out-of-Pocket Insulin Costs.
For this new Part D Savings Model, there will be certain plans that cover certain medications (e.g. Insulin) that will have additional coverage throughout the year, thus keeping a flat copay of $35/month or less.
Current Model Out of Pocket Costs Illustrative Example with One Insulin with retail cost of $435/month
- January = $435 (deductible)
- February through September = $50/month copay during Initial Coverage Level
- October = ~$80 copay (partial month of Coverage Gap)
- November = ~$109 (25% of full retail cost while in Coverage Gap)
- December = ~$109 (25% of full retail cost while in Coverage Gap)
Total ~ $1,135 annual cost
New Part D Savings Model Out of Pocket Costs Illustrative Example with One Insulin with retail cost of $435/month
- January - December = $35/month copay
Total ~ $420 annual cost
Projected Annual Savings ~$700
CMS held a public webinar on Thursday, March 12, 2020. One of my concerns from this presentation is that this new Model is Voluntary for the Part D Plans and the Drug Manufacturers. Most of the cost savings (about $250 Million in projected savings) is coming from the Drug Manufacturer, so my concern was that the Drug Manufacturers wouldn't participate since this is a voluntary model.
However, I was excited to find an article from Lilly indicating their planned participation in the model for 2021. This is really great news for Medicare beneficiaries and we look forward to seeing the Savings when we run the Part D reports in October 2020 for the 2021 Part D Plans.
Finally some good news for Diabetics taking Insulin!
Below is a link to an article that was written on the Panel that I hosted in D.C. a few weeks ago with Congressman Allyson Schwartz.
See bio here